VRS.L

Versarien Plc
Versarien PLC - £1.93m strategic investment by Graphene Lab
9th April 2021, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9534U
Versarien PLC
09 April 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

9 April 2021

Versarien plc

("Versarien" or the "Company")

£1.93 million strategic investment in Versarien by Graphene Lab

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce that it has entered into a wide-ranging series of agreements (together the "Agreement") with Graphene Lab Co Ltd ("Graphene Lab"), a South Korean based company specialising in chemical vapor deposition ("CVD") graphene, including sensors, OLEDs, and flexible transparent touch panels, with the intention of advancing both Versarien's and Graphene Lab's proposed activities in South Korea.  This follows the Company's acquisition of certain graphene production related assets and intellectual property from South Korea based Hanwha Aerospace Co. Ltd (the "Acquisition"), as announced on 22 December 2020.

 

In addition, Graphene Lab has made a strategic investment of £1.93 million in the Company through a subscription for 4,280,000 new Ordinary Shares (the "Subscription Shares") at an issue of price of 45 pence per Ordinary Share (the "Issue Price").  The Subscription Shares, which represent 2.2% of the enlarged share capital of the Company, will be subject to a 12-month lock-in.  

 

Further information on the Agreement

 

Graphene Lab has entered into the Agreement with the Company's wholly owned subsidiary in South Korea, Versarien Korea Ltd ("Versarien Korea").  The Agreement covers a number of matters pertaining to Versarien and Graphene Lab's proposed activities in South Korea.  The main elements of the Agreement are summarised below:

 

·    The Agreement provides a licence to Graphene Lab to utilise, exclusively in South Korea, 14 of the patents acquired through the Acquisition for a 5% royalty on sales payable to Versarien;

·    Under the Agreement, Graphene Lab has the right to use certain Versarien trademarks on payment of a 2% royalty on sales to Versarien;

·      Graphene Lab will acquire 15% of the shares in Versarien Korea at their nominal value and the board of Versarien Korea will, in due course, comprise five directors, of which four will be nominated by Versarien and one by Graphene Lab;

·    Graphene Lab has leased new premises in South Korea and Versarien Korea is taking a sub-lease over part of that facility, to locate the equipment acquired as part of the Acquisition.  Additionally, Versarien Korea and Graphene Lab have agreed to share equipment at an agreed daily rate; and

·      Graphene Lab will provide certain operator and maintenance support to Versarien Korea at an agreed cost.

 

Admission and Total Voting Rights

 

The Subscription Shares will rank pari passu with the existing Ordinary Shares and application has been made for their admission to trading on AIM ("Admission").  It is expected that Admission will become effective on or around 13 April 2021.

 

Following the issue of the Subscription Shares, the Company will have 194,149,790, ordinary shares of 1 pence each in issue.  The figure of 194,149,790 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Neill Ricketts, CEO of Versarien, commented: "We are delighted to have secured this agreement with Graphene Lab, which will enable us to advance our plans in South Korea, following the Acquisition in December.  I am also pleased that our partnership with Graphene Lab has been further reinforced by the stake they have taken in Versarien.  We are excited by the opportunities for Versarien in South Korea, including for new product developments, and we look forward to providing updates in due course."

 

Enquiries:

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

+44 (0)1242 269 122

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Ewan Leggat, Adam Cowl

+44 (0)20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Ciaran Walsh

+44 (0)20 3207 7800

Yellow Jersey (Investor Relations) 

Charles Goodwin

Henry Wilkinson

Versarien@yellowjerseypr.com

+44 (0)774 778 8221

Notes to Editors:

 

Versarien Plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries.

 

For further information please see: http://www.versarien.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGXGDSIXGDGBC ]]>
TwitterFacebookLinkedIn